vs

Side-by-side financial comparison of Sol-Gel Technologies Ltd. (SLGL) and USCB FINANCIAL HOLDINGS, INC. (USCB). Click either name above to swap in a different company.

USCB FINANCIAL HOLDINGS, INC. is the larger business by last-quarter revenue ($22.2M vs $17.3M, roughly 1.3× Sol-Gel Technologies Ltd.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 6.1%, a 61.1% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 14.7%).

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

USCB Financial Holdings, Inc. is a U.S.-headquartered bank holding company that offers comprehensive retail and commercial banking services, including deposit products, personal and business loans, wealth management, and digital banking tools. It primarily serves individual consumers, small and medium-sized enterprises, and local corporate clients across its operating regions in the United States, prioritizing personalized customer experiences and community-oriented financial services.

SLGL vs USCB — Head-to-Head

Bigger by revenue
USCB
USCB
1.3× larger
USCB
$22.2M
$17.3M
SLGL
Growing faster (revenue YoY)
SLGL
SLGL
+203.0% gap
SLGL
217.7%
14.7%
USCB
Higher net margin
SLGL
SLGL
61.1% more per $
SLGL
67.3%
6.1%
USCB

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
SLGL
SLGL
USCB
USCB
Revenue
$17.3M
$22.2M
Net Profit
$11.6M
$1.4M
Gross Margin
Operating Margin
65.1%
14.7%
Net Margin
67.3%
6.1%
Revenue YoY
217.7%
14.7%
Net Profit YoY
487.6%
-80.3%
EPS (diluted)
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLGL
SLGL
USCB
USCB
Q4 25
$22.2M
Q3 25
$25.0M
Q2 25
$17.3M
$24.4M
Q1 25
$22.8M
Q4 24
$23.0M
Q3 24
$21.5M
Q2 24
$5.4M
$20.5M
Q1 24
$17.6M
Net Profit
SLGL
SLGL
USCB
USCB
Q4 25
$1.4M
Q3 25
$8.9M
Q2 25
$11.6M
$8.1M
Q1 25
$7.7M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
$2.0M
$6.2M
Q1 24
$4.6M
Operating Margin
SLGL
SLGL
USCB
USCB
Q4 25
14.7%
Q3 25
47.3%
Q2 25
65.1%
44.0%
Q1 25
44.2%
Q4 24
39.6%
Q3 24
42.5%
Q2 24
29.9%
39.8%
Q1 24
34.3%
Net Margin
SLGL
SLGL
USCB
USCB
Q4 25
6.1%
Q3 25
35.8%
Q2 25
67.3%
33.4%
Q1 25
33.5%
Q4 24
30.0%
Q3 24
32.3%
Q2 24
36.4%
30.3%
Q1 24
26.2%
EPS (diluted)
SLGL
SLGL
USCB
USCB
Q4 25
Q3 25
$0.45
Q2 25
$4.17
Q1 25
Q4 24
Q3 24
$0.35
Q2 24
$0.71
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLGL
SLGL
USCB
USCB
Cash + ST InvestmentsLiquidity on hand
$24.3M
$38.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$31.9M
$217.2M
Total Assets
$39.3M
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLGL
SLGL
USCB
USCB
Q4 25
$38.5M
Q3 25
$56.8M
Q2 25
$24.3M
$54.8M
Q1 25
$98.0M
Q4 24
$77.0M
Q3 24
$38.5M
Q2 24
$26.5M
$77.3M
Q1 24
$126.5M
Stockholders' Equity
SLGL
SLGL
USCB
USCB
Q4 25
$217.2M
Q3 25
$209.1M
Q2 25
$31.9M
$231.6M
Q1 25
$225.1M
Q4 24
$215.4M
Q3 24
$213.9M
Q2 24
$34.9M
$201.0M
Q1 24
$195.0M
Total Assets
SLGL
SLGL
USCB
USCB
Q4 25
$2.8B
Q3 25
$2.8B
Q2 25
$39.3M
$2.7B
Q1 25
$2.7B
Q4 24
$2.6B
Q3 24
$2.5B
Q2 24
$42.0M
$2.5B
Q1 24
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLGL
SLGL
USCB
USCB
Operating Cash FlowLast quarter
$42.8M
Free Cash FlowOCF − Capex
$42.5M
FCF MarginFCF / Revenue
191.4%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
31.40×
TTM Free Cash FlowTrailing 4 quarters
$95.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLGL
SLGL
USCB
USCB
Q4 25
$42.8M
Q3 25
$20.1M
Q2 25
$18.0M
Q1 25
$14.6M
Q4 24
$34.8M
Q3 24
$11.3M
Q2 24
$18.3M
Q1 24
$8.1M
Free Cash Flow
SLGL
SLGL
USCB
USCB
Q4 25
$42.5M
Q3 25
$20.0M
Q2 25
$18.0M
Q1 25
$14.6M
Q4 24
$34.5M
Q3 24
$11.2M
Q2 24
$18.2M
Q1 24
$8.0M
FCF Margin
SLGL
SLGL
USCB
USCB
Q4 25
191.4%
Q3 25
80.3%
Q2 25
73.7%
Q1 25
63.9%
Q4 24
150.2%
Q3 24
52.2%
Q2 24
88.8%
Q1 24
45.4%
Capex Intensity
SLGL
SLGL
USCB
USCB
Q4 25
1.4%
Q3 25
0.5%
Q2 25
0.2%
Q1 25
0.2%
Q4 24
1.4%
Q3 24
0.4%
Q2 24
0.4%
Q1 24
0.5%
Cash Conversion
SLGL
SLGL
USCB
USCB
Q4 25
31.40×
Q3 25
2.25×
Q2 25
2.22×
Q1 25
1.91×
Q4 24
5.05×
Q3 24
1.63×
Q2 24
2.95×
Q1 24
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons